Skip to main content
Journal cover image

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.

Publication ,  Journal Article
Daubert, JP; Zareba, W; Rosero, SZ; Budzikowski, A; Robinson, JL; Moss, AJ
Published in: Am Heart J
April 2007

Long QT syndrome (LQTS) is one of several primary electrical disorders or hereditary arrhythmia syndromes along with the short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. Since its initial recognition in 1957 by Jervell and Lange-Nielsen (Am Heart J. 1957;54:59-68), LQTS has been intimately associated with risk for sudden cardiac death. The implantable defibrillator was developed by Morowski et al (N Engl J Med. 1980;303:322-4) as a treatment to prevent sudden cardiac death. Consequently, implanted cardioverter-defibrillator therapy deserves serious consideration as an important therapy for LQTS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2007

Volume

153

Issue

4 Suppl

Start / End Page

53 / 58

Location

United States

Related Subject Headings

  • Long QT Syndrome
  • Humans
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daubert, J. P., Zareba, W., Rosero, S. Z., Budzikowski, A., Robinson, J. L., & Moss, A. J. (2007). Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J, 153(4 Suppl), 53–58. https://doi.org/10.1016/j.ahj.2007.01.025
Daubert, James P., Wojciech Zareba, Spencer Z. Rosero, Adam Budzikowski, Jennifer L. Robinson, and Arthur J. Moss. “Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.Am Heart J 153, no. 4 Suppl (April 2007): 53–58. https://doi.org/10.1016/j.ahj.2007.01.025.
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr;153(4 Suppl):53–8.
Daubert, James P., et al. “Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.Am Heart J, vol. 153, no. 4 Suppl, Apr. 2007, pp. 53–58. Pubmed, doi:10.1016/j.ahj.2007.01.025.
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr;153(4 Suppl):53–58.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

April 2007

Volume

153

Issue

4 Suppl

Start / End Page

53 / 58

Location

United States

Related Subject Headings

  • Long QT Syndrome
  • Humans
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology